Form 4: L3Harris Technologies Executive Zoiss Reports Stock Transactions
SEC Form 4 Filing
Edward J. Zoiss, an executive at L3Harris Technologies, reports the acquisition and disposal of common stock and derivative securities, including performance stock units, stock options, and restricted stock units.
Summary
- Edward J. Zoiss, Pres., Space & Airborne Sys. at L3Harris Technologies, filed a Form 4 detailing changes in beneficial ownership.
- On February 28, 2025, Zoiss acquired 5,046 shares of common stock related to the settlement of performance stock units at a price of $0.
- He also disposed of 1,685 shares to cover tax obligations at a price of $206.11.
- Following these transactions, Zoiss directly owns 32,403.4 shares of L3Harris Technologies common stock.
- Zoiss also acquired 14,228 non-qualified stock options with an exercise price of $206.11, exercisable starting February 28, 2026, and 3,397 restricted stock units vesting on February 28, 2028.
- He also acquired 4,711 performance stock units that vested on January 3, 2025, and were settled on February 28, 2025.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The transactions are part of a standard compensation package. There are no indications of unusual activity or concerns.
Positives
- The acquisition of performance stock units and restricted stock units suggests confidence in the company's future performance.
- The granting of stock options aligns the executive's interests with those of the shareholders.
Negatives
- The disposal of shares to cover tax obligations, while common, slightly reduces the executive's stake in the company.
Risks
- Future vesting of restricted stock units and exercisability of stock options are contingent upon continued employment.
- The value of the stock options is dependent on the future stock price of L3Harris Technologies.
Future Outlook
The executive's future compensation is tied to the performance of L3Harris Technologies through stock options and restricted stock units, incentivizing long-term growth.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies and are closely monitored by investors for insights into management's confidence in the company's prospects.
Comparison to Industry Standards
- Stock option and restricted stock unit grants are standard compensation practices among large technology and defense companies like Lockheed Martin, Boeing, and Northrop Grumman.
- The vesting schedules and performance-based components are also typical for executive compensation packages in this sector.
- The specific amounts and terms would need to be compared against peer companies to determine if they are above or below industry averages.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect standard executive compensation practices.
- Employees may be indirectly affected by the executive's incentives to improve company performance.
Key Dates
| Date | Description |
|---|---|
| 02/25/2022 | Date of original grant of performance stock units that settled on 02/28/2025. |
| 01/03/2025 | Performance stock units vested. |
| 02/28/2025 | Date of transactions: acquisition and disposal of shares, settlement of performance stock units, grant of stock options and restricted stock units. |
| 02/28/2026 | First vesting date for the non-qualified stock options. |
| 02/28/2027 | Second vesting date for the non-qualified stock options. |
| 02/28/2028 | Final vesting date for the non-qualified stock options and vesting date for the restricted stock units. |
| 02/28/2035 | Expiration date for the non-qualified stock options. |
| 03/04/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.